Last reviewed · How we verify
Osteocel Plus
At a glance
| Generic name | Osteocel Plus |
|---|---|
| Sponsor | NuVasive |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)
- Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)
- Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)
- Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)
- Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)
- Assessment of the Quality and Quantity of Bone Regeneration (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Osteocel Plus CI brief — competitive landscape report
- Osteocel Plus updates RSS · CI watch RSS
- NuVasive portfolio CI